BRCA1/2 mutations and triple negative breast cancers
Breast Disease · 15.03.2011 · 32 (1-2) · 25-33
DOI: 10.3233/bd-2010-0306 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Breast Disease, erschienen am 15.03.2011. Verfasst von Beth N Peshkin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Fisher Center for Familial Cancer Research, Georgetown University, Lombardi Comprehensive Cancer Center, Washington, DC 20007-2401, USA. peshkinb@geo…. Hauptthemen laut MEDLINE: Genes, BRCA1, Genes, BRCA2. Die Arbeit wurde bisher 129-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Fisher Center for Familial Cancer Research, Georgetown University, Lombardi Comprehensive Cancer Center, Washington, DC 20007-2401, USA. peshkinb@georgetown.edu
Förderung
- NCI NIH HHS
Zitieren
APA
Peshkin, B. N., Alabek, M. L., & Isaacs, C. (2011). BRCA1/2 mutations and triple negative breast cancers. Breast Disease, 32(1-2), 25-33. https://doi.org/10.3233/bd-2010-0306
Vancouver
Peshkin BN, Alabek ML, Isaacs C. BRCA1/2 mutations and triple negative breast cancers. Breast Disease. 2011;32(1-2):25-33. doi:10.3233/bd-2010-0306
BibTeX
@article{Peshkin2011,
author = {Peshkin, Beth N and Alabek, Michelle L and Isaacs, Claudine},
title = {BRCA1/2 mutations and triple negative breast cancers},
journal = {Breast Disease},
year = {2011},
volume = {32},
number = {1-2},
pages = {25--33},
doi = {10.3233/bd-2010-0306}
}
EUVIMED